CPB
55
-2
AEE
63
2
AN
57
5
CMCSA
59
2
WEC
45
2
K
62
2
VRSN
60
3
BWA
56
3
C
60
2
IBM
78
-3
OKE
67
2
RRC
59
3
MAR
65
2
CVS
58
6
ES
56
8
AAL
62
-3
PYPL
58
2
YUM
56
4
TEL
68
2
INTU
58
-5
CPB
55
-2
AEE
63
2
AN
57
5
CMCSA
59
2
WEC
45
2
K
62
2
VRSN
60
3
BWA
56
3
C
60
2
IBM
78
-3
OKE
67
2
RRC
59
3
MAR
65
2
CVS
58
6
ES
56
8
AAL
62
-3
PYPL
58
2
YUM
56
4
TEL
68
2
INTU
58
-5
Financhill
Back

Akero Therapeutics Vs. Triumph Financial Industry Stock Comparison

Buy
55

AKRO
Akero Therapeutics

Last Price:
28.25
Seasonality Move:
4.08%
Sell
46

TFIN
Triumph Financial

Last Price:
78.51
Seasonality Move:
14.75%
Buy
55
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.24. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $78.42. The Score for TFIN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.24
    The current trend is moderately bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $78.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing slight buying pressure.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.68 Buy
Relative Strength Index (14 RSI): 58.1 Buy
Chaikin Money Flow: -603016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.1 - 27.98) Buy
Bollinger Bands (100): (21.4 - 27.18) Buy

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 42.14 Sell
Chaikin Money Flow: 13163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.9 - 83.58) Sell
Bollinger Bands (100): (75.05 - 85.81) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.13 Buy
20-day SMA: 27.07 Buy
50-day SMA: 26.44 Buy
200-day SMA: 23.72 Buy
8-day EMA: 28.08 Buy
20-day EMA: 27.34 Buy
50-day EMA: 26.3 Buy
200-day EMA: 25.72 Buy

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.41 Sell
20-day SMA: 80.54 Sell
50-day SMA: 83.16 Sell
200-day SMA: 77.88 Buy
8-day EMA: 79.57 Sell
20-day EMA: 80.7 Sell
50-day EMA: 81.52 Sell
200-day EMA: 77.31 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.90 per share, and an increase next year of $1.31 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):